Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.773,94
0,43%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ContextLogic Inc (LOGC) ContextLogic Inc (LOGC) Notizie

LOGC

ContextLogic (LOGC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LOGC
DataOraFonteTitoloSimboloCompagnia
10/02/202322:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOGCContextLogic Inc
29/11/202222:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LOGCContextLogic Inc
21/11/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOGCContextLogic Inc
16/11/202222:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
16/11/202222:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOGCContextLogic Inc
16/11/202215:56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LOGCContextLogic Inc
16/11/202214:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOGCContextLogic Inc
16/11/202214:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOGCContextLogic Inc
14/11/202214:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LOGCContextLogic Inc
14/11/202214:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
14/11/202214:00PR Newswire (US)LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:LOGCContextLogic Inc
20/10/202214:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOGCContextLogic Inc
18/10/202222:14Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOGCContextLogic Inc
18/10/202222:04Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOGCContextLogic Inc
13/10/202222:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LOGCContextLogic Inc
03/10/202222:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOGCContextLogic Inc
03/10/202217:20Dow Jones NewsLogicBio Therapeutics Shares Soar on Takeover by AstraZenecaNASDAQ:LOGCContextLogic Inc
03/10/202216:50TipRanksAnalysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
03/10/202214:19TipRanksAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per ShareNASDAQ:LOGCContextLogic Inc
03/10/202213:57Dow Jones NewsAstraZeneca to Buy LogicBio Therapeutics for $68 MillionNASDAQ:LOGCContextLogic Inc
03/10/202213:15Business WireAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
21/09/202214:30PR Newswire (US)LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONENASDAQ:LOGCContextLogic Inc
19/08/202204:15TipRanksLogicbio Therapeutics (LOGC) Receives a Buy from William BlairNASDAQ:LOGCContextLogic Inc
16/08/202210:55TipRanksJMP Securities Keeps Their Buy Rating on Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
15/08/202213:05PR Newswire (US)LogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:LOGCContextLogic Inc
21/06/202214:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LOGCContextLogic Inc
24/05/202211:06TipRanksWilliam Blair Thinks Logicbio Therapeutics’ Stock is Going to RecoverNASDAQ:LOGCContextLogic Inc
18/05/202213:40TipRanksAnalysts Offer Insights on Healthcare Companies: Compugen (CGEN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
18/05/202206:45TipRanksAnalysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
17/05/202214:30PR Newswire (US)LogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferenceNASDAQ:LOGCContextLogic Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LOGC

La tua Cronologia

AMEX
PLTL
Principal US SmallCap Ad...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network